液体平衡与重症及非重症SARS-CoV-2成人呼吸衰竭的不同关联:一项回顾性队列研究
该回顾性队列研究纳入2020年3月至2022年7月在某学术医疗系统内因SARS-CoV-2住院的4254例成人(中位年龄58岁,52.9%男性,中位住院4.5天),其中67.2%需要呼吸支持、12.7%接受有创通气、13.4%死亡。研究采用累积logistic回归和相邻类别logistic回归分析每日净液体平衡与次日改良世界卫生组织临床量表(1分住院无需呼吸支持至5分死亡或出院转临终关怀)的关联,并调整人口学、合并症、医院类型、血管活性药、正性肌力药、肾脏替代治疗及未测量尿量。结果显示,重症患者正液体平衡与后续机械通气几率升高相关(每升OR 1.48,95%CI 1.41-1.55),与死亡几率升高相关(OR 1.15,95%CI 1.08-1.23);非重症低流量氧疗患者正液体平衡与呼吸状态改善相关(OR 0.89,95%CI 0.86-0.92)。作者认为正液体平衡的影响因病情严重程度而异,提示SARS-CoV-2呼吸衰竭不同阶段可能存在不同生理或临床机制。
要点
- 重症SARS-CoV-2患者每增加1 L正液体平衡,后续机械通气几率升高(OR 1.48,95%CI 1.41-1.55)。
- 重症SARS-CoV-2患者每增加1 L正液体平衡,死亡几率升高(OR 1.15,95%CI 1.08-1.23)。
- 非重症低流量氧疗患者每增加1 L正液体平衡,呼吸状态改善(OR 0.89,95%CI 0.86-0.92)。
- 4254例住院患者中67.2%需呼吸支持、12.7%接受有创通气、13.4%死亡。
- 正液体平衡对呼吸结局的影响因病情严重程度不同而方向相反,提示机制可能不同。
适用人群与场景
- 2020年3月至2022年7月在某学术医疗系统内因SARS-CoV-2住院、入院±7天内的成人患者。
- 共4254例,中位年龄58岁(41-70),52.9%男性,中位住院4.5天(2.5-8.1)。
- 其中2860例(67.2%)需要呼吸支持,539例(12.7%)接受有创通气,571例(13.4%)死亡。
诊断标准与关键阈值
- 主要结局为改良世界卫生组织临床量表,范围1分(住院,无需呼吸支持)至5分(死亡或出院转临终关怀)。
研究设计与关键结果
- 研究类型为回顾性队列研究,样本量4254例,人群为SARS-CoV-2住院成人,暴露为每日净液体平衡,结局为次日改良世界卫生组织临床量表。
- 采用累积logistic回归和相邻类别logistic回归,调整人口学、合并症、医院类型、血管活性药、正性肌力药、肾脏替代治疗及未测量尿量。
- 重症成人中,正液体平衡与后续机械通气几率升高相关(每升OR 1.48,95%CI 1.41-1.55),与死亡几率升高相关(OR 1.15,95%CI 1.08-1.23)。
- 非重症低流量氧疗患者中,正液体平衡与呼吸状态改善相关(OR 0.89,95%CI 0.86-0.92)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为正液体平衡对SARS-CoV-2呼吸衰竭的影响因病情严重程度而异,提示不同阶段可能存在不同生理或临床机制。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Conservative fluid management improves outcomes in mechanically ventilated adults with acute respiratory distress syndrome, but its impact across the broader spectrum of acute respiratory failure is less clear. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic provided an opportunity to assess the relationship between daily fluid balance and respiratory status across varying degrees of respiratory impairment with a relatively uniform lung injury mechanism.
METHODS: Retrospective study of adults hospitalized with SARS-CoV-2 within ±7 days of hospital admission in an academic medical system (March 2020-July 2022). The primary outcome was a modified World Health Organization Clinical Scale from 1 (Hospitalized, no respiratory support) to 5 (Death or discharge to hospice). Associations between daily net fluid balance and next-day modified World Health Organization Clinical Scale were tested using cumulative logistic regression and adjacent-categories logistic regression, adjusting for demographics, comorbidities, hospital type, vasopressors, inotropes, renal replacement therapy, and unmeasured urine outputs.
RESULTS: Among 4,254 patients (median age 58 [41-70]; 52.9% male; median hospital stay 4.5 [2.5-8.1] days), 2,860 (67.2%) required respiratory support, 539 (12.7%) received invasive ventilation, and 571 (13.4%) died. In critically ill adults, positive fluid balance was associated with higher odds of subsequent mechanical ventilation (odds ratio [OR] per L 1.48, 95% confidence interval [CI] 1.41-1.55) or death (OR 1.15, 95% CI 1.08-1.23). Among noncritically ill patients on low-flow oxygen, positive fluid balance was associated with improved respiratory status (OR 0.89, 95% CI 0.86-0.92).
CONCLUSIONS: Positive fluid balance had divergent effects by illness severity, suggesting distinct physiologic or clinical mechanisms across the spectrum of SARS-CoV-2 respiratory failure.
参考来源
- Kerchberger VE, Lee AX, DeCorte JA, et al. Fluid Balance is Associated with Differential Effects on Respiratory Failure between Critically Ill and Noncritically Ill Adults with SARS-CoV-2: a Retrospective Cohort Study. Shock. 2026. PMID: 41670545. doi:10.1097/SHK.0000000000002804
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。